Kinapse

Showing 11 posts of 26 posts found.

Kinapse CEO stepping down

September 24, 2010
Kinapse

24 September, 2010London, UKThe Board of Directors of Kinapse Ltd. today announced that Co-founder Shalabh Kumar has stepped down as …

Realising outsourcing’s potential

September 20, 2010
Sales and Marketing Kinapse, White paper

IntroductionAs the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2

August 26, 2010
Research and Development Kinapse, White paper, life sciences, pharma

With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 1

August 11, 2010
Research and Development Kinapse, life sciences, pharma

Valuations are essential components of effective transactions in the life sciences industry

Medical Affairs at the centre of life sciences innovation

August 11, 2010
Research and Development Kinapse, Medical Affairs

In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …

What might the NHS white paper mean for Pharma commercial models?

July 16, 2010
Sales and Marketing Kinapse, NHS, White paper, commercial model, life sciences, pharma

Earlier this year we published a white paper on the new commercial realities and their implications for Life Sciences companies.

Real World Development: Increasing value for patients

June 30, 2010
Research and Development Kinapse, drug development

The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …

Medical Affairs at the Centre of Life Sciences Innovation

June 22, 2010
Research and Development Kinapse, Medical Affairs, Real World Development, consulting, outsourcinf

In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …

The Gateway to Local Adoption Series

Latest content